Categories AlphaGraphs, Earnings, Health Care
Trxade (MEDS) delivers another quarter of strong revenue growth
Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales. The top-line was way ahead of the average Wall Street consensus of $3.01 million.
Meanwhile, net income came in at $0.02 per share, a cent shy of the street consensus.
CEO Suren Ajjarapu said in a statement, “The COVID-19 pandemic has only underscored the importance of an integrated platform like ours, which enables independent pharmacies to remain competitive and profitable in a changing drug procurement marketplace.”
MEDS stock shot up 34% during after-market hours on the stronger-than-expected revenues. The stock has declined 18% since the beginning of this year.
In the third quarter, the Tampa, Florida-based firm added 144 new independent pharmacies to its network. The company now has approximately 11,800 registered pharmacy members.
Trxade, which brings together independent pharmacies under one umbrella through its web-based purchasing platform, is present in all 50 states and is rapidly adding pharmacies to its network.
Prior performance
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to